Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis

High-density lipoproteins (HDL) have received considerable interest as a target for the development of novel anti-atherosclerotic agents beyond conventional approaches to lipid lowering. While a number of approaches have focused on modifying remodeling and expression pathways implicated in the regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bartolo, Belinda A., Schwarz, Nisha, Andrews, Jordan, Nicholls, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206363/
https://www.ncbi.nlm.nih.gov/pubmed/28144273
http://dx.doi.org/10.5114/aoms.2016.60941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206363/
https://www.ncbi.nlm.nih.gov/pubmed/28144273
http://dx.doi.org/10.5114/aoms.2016.60941

Ejemplares similares